Literature DB >> 9466700

Suppression of apoptosis by overexpression of Bcl-2 or Bcl-xL promotes survival and mutagenesis after oxidative damage.

C Cherbonnel-Lasserre1, M K Dosanjh.   

Abstract

Apoptosis is the physiological process by which unwanted cells in an organism are killed. Bcl-2, a membrane-bound cytoplasmic protein, and its close relative Bcl-xL, are both effective inhibitors of apoptosis induced by a wide variety of stimuli in many different cell types. In a previous study, we reported that suppression of apoptosis by Bcl-2 or Bcl-xL, markedly elevates the levels of radiation-induced mutations at the specific locus thymidine kinase. We investigated the effect of the Bcl-2 or Bcl-xL overproduction on hydrogen peroxide-induced mutagenesis. Oxidative DNA damage has been implicated in biological processes such as mutagenesis, carcinogenesis and aging. Overexpression of either Bcl-2 or Bcl-xL enhances oxidative stress mutagenesis in cells with wild type p53 as well as with mutated p53 protein. These results support the hypothesis that apoptosis plays a crucial role in maintaining genomic integrity by selectively eliminating highly mutated cells from the population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9466700     DOI: 10.1016/s0300-9084(97)82011-1

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  16 in total

1.  Spontaneous and oxidative stress-induced programmed cell death in lymphocytes from patients with ataxia telangiectasia (AT).

Authors:  R Schubert; J Reichenbach; N Royer; M Pichler; S Zielen
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

Review 2.  Cholecystectomy and the risk of alimentary tract cancers: a systematic review.

Authors:  Maria Coats; Sami M Shimi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 3.  The Role of Secondary Metabolites on Gynecologic Cancer Therapy: Some Pathways and Mechanisms.

Authors:  Mürşide Ayşe Demirel; İpek Süntar
Journal:  Turk J Pharm Sci       Date:  2017-11-20

4.  Immediate and delayed leukocyte apoptosis in two models of peritonitis.

Authors:  J F Kuhn; C J Godshall; M J Scott; G A Franklin; S A Rowe; J C Peyton; W G Cheadle
Journal:  Inflammation       Date:  2001-12       Impact factor: 4.092

5.  Gallstones and the Risk of Gallbladder Cancer Mortality: A Cohort Study.

Authors:  Seungho Ryu; Yoosoo Chang; Kyung Eun Yun; Hyun-Suk Jung; Jun Ho Shin; Hocheol Shin
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

6.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

7.  Detrimental effects of antiapoptotic treatments in spinal cord injury.

Authors:  Diana M Cittelly; Olivera Nesic; Kathia Johnson; Claire Hulsebosch; J Regino Perez-Polo
Journal:  Exp Neurol       Date:  2007-03-07       Impact factor: 5.330

Review 8.  Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability.

Authors:  Hu Wang; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Jong-Hun Lee; Ah-Ng Tony Kong
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

9.  Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells.

Authors:  Ju-Hee Kang; Ki-Hoon Song; Kyung-Chae Jeong; Sunshin Kim; Changsun Choi; Chang Hoon Lee; Seung Hyun Oh
Journal:  BMC Cancer       Date:  2011-08-04       Impact factor: 4.430

10.  The histological and immunohistochemical aspects of bile reflux in patients with gastroesophageal reflux disease.

Authors:  Andreas Nakos; Georgios Kouklakis; Michail Pitiakoudis; Petros Zezos; Eleni Efraimidou; Alexandra Giatromanolaki; Alexandros Polychronidis; Nikolaos Liratzopoulos; Efthimios Sivridis; Konstantinos Simopoulos
Journal:  Gastroenterol Res Pract       Date:  2011-07-24       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.